Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,611 GBX | -8.82% | -6.98% | +11.61% |
03:03pm | GSK Says Cancer Drug Jemperli Shows 100% Clinical Response Rate in Long-Term Data From Mid-Stage Trial | MT |
03:02pm | GSK immunotherapy bowel cancer drug works for 100% of patients | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.61% | 91.66B | |
+40.73% | 739B | |
+31.74% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.53% | 240B | |
+9.54% | 210B | |
-5.36% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Lab at Heart of Zantac Cancer Claims Files Whistleblower Lawsuit Against GSK